myopathy

Search with Google Search with Bing
Information
Disease name
myopathy
Disease ID
DOID:423
Description
"A muscular disease in which the muscle fibers do not function resulting in muscular weakness." [url:http\://en.wikipedia.org/wiki/Myopathy]
Disease area statistics
Chromosome band
Gene symbol Chromosome Start Stop The number of variant
EARS2 16 23,525,024 23,557,344 8
SUCLA2 13 47,942,656 48,001,273 4
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT00937001 Active, not recruiting N/A Critical Illness Myopathy as a Cause of Debilitating ICU-Acquired Weakness November 2008 December 2025
NCT04881214 Active, not recruiting N/A COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program July 1, 2020 June 30, 2023
NCT03751644 Completed N/A Peripherical Neuromuscular Electrical Stimulation in Systemic Autoimmune Myopathies November 1, 2018 April 29, 2021
NCT03141749 Completed Venous Thromboembolism in DM1 January 2000 January 2017
NCT02765828 Completed Identification of Tongue Involvement in Late-Onset Pompe Disease May 25, 2016 July 15, 2019
NCT01047163 Completed Maintenance of Muscle Mass in Older People: the Negative Impact of Statin Therapy June 2009 December 2012
NCT02706314 Completed Impact of Human Blood Serum From Critically Ill Patients on Human Colon Neuronal Networks. March 2016 April 16, 2019
NCT00120055 Completed Phase 4 Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity February 2005 April 2005
NCT02442986 Completed Neurological Outcome in Surgical and Non-surgical Septic Patients November 2012 March 2017
NCT01530841 Completed N/A Efficacy and Tolerance of AVAPS Mode in Myotonic Dystrophy July 2012 May 2016
NCT01547767 Completed Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy February 1, 2012 March 3, 2021
NCT01642056 Completed Phase 1/Phase 2 EPI-743 for Metabolism or Mitochondrial Disorders September 1, 2012 September 24, 2019
NCT01702987 Completed N/A Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS October 2012 October 2013
NCT02011282 Completed N/A Electro-Neuro-Muscular Stimulation in ICU October 2013 March 2015
NCT01790178 Completed N/A Ultrasound in Muscle Biopsy February 2013 October 2015
NCT02104921 Completed Innovative Ultrasound Technology in Neuromuscular Disease December 1, 2013 March 1, 2020
NCT06374719 Recruiting WiTNNess - TNNT1 Myopathy Natural History Study September 23, 2018 June 1, 2027
NCT01353430 Recruiting Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD) November 15, 2007 December 2026
NCT03660969 Recruiting Reliability of Cardiac Troponins for the Diagnosis of Myocardial Infarction in the Presence of Skeletal Muscle Disease January 1, 2018 January 1, 2027
NCT03749538 Recruiting N/A Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies October 1, 2018 May 7, 2024
NCT03998540 Recruiting Improvement of DIAgnostic and Phenotype-genotype Correlation Studies in Patients With MYOpathy Suspected of TITinopathy December 5, 2019 May 5, 2025
NCT04678635 Recruiting N/A Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies December 12, 2020 May 7, 2024
NCT05599568 Recruiting N/A Repeated Bout Effect i Neuromuscular Diseases May 15, 2022 May 30, 2025
NCT00278564 Terminated Phase 1 Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases September 2005 July 2016
NCT02247895 Terminated N/A Treatment of Muscle Weakness in Critically Ill Patients December 2016 February 2018
NCT03633565 Unknown status Phase 4 Comparative Study of Strategies for Management of Duchenne Myopathy (DM) September 2018 November 2021
NCT00549029 Unknown status The Association of Genetic Polymorphisms With Statin-Induced Myopathy. August 2007 January 2008
NCT00767130 Unknown status DNA Diagnostic System for Statin Safety and Efficacy January 2007 December 2009
NCT04941079 Unknown status Safety and Efficacy of Inactivated SARS-CoV-2 Vaccine in Immune-related Myopathy (Myasthenia Gravis and Inflammatory Myopathy) Patients :a Prospective Observational Study June 30, 2021 December 31, 2021
NCT01225614 Unknown status Phase 3 Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive October 2010 December 2018
NCT03042286 Unknown status SAPhIRE Statin Adverse Drug Reaction March 2015 January 2020
NCT02235220 Unknown status N/A Reduction of Masticatory Muscle Activity by Restoring Canine Guidance September 2014 December 2015
NCT01022450 Unknown status Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients November 2009
NCT00990834 Withdrawn N/A Muscle Characteristics Associated With Statin Therapy November 2009 June 2011
NCT02124070 Withdrawn Phase 1/Phase 2 Therapeutic Effect of Recombinant Human Growth Hormone (rhGH) on the Myopathy of Cystinosis March 26, 2014 November 6, 2015
NCT01395563 Withdrawn N/A Strength Training on Pancreatic Cancer January 2009 December 2011
Disase is a (Disease Ontology)
DOID:66
Cross Reference ID (Disease Ontology)
ICD10CM:G72.9
Cross Reference ID (Disease Ontology)
ICD9CM:359.9
Cross Reference ID (Disease Ontology)
MESH:D009135
Cross Reference ID (Disease Ontology)
NCI:C101216
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:155094005
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0026848
HPO alt_id (Human Phenotype Ontology)
HP:0003569
HPO alt_id (Human Phenotype Ontology)
HP:0003705
HPO alt_id (Human Phenotype Ontology)
HP:0003742
HPO alt_id (Human Phenotype Ontology)
HP:0003802
HPO Human Phenotype ID (Human Phenotype Ontology)
HP:0003198